Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 KEY INDUSTRY INSIGHTS
2.2 MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RIS RISK ANALYSIS RISK ANALYSIS K ANALYSIS
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RECESSION IMPACT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 RANGES/SCENARIO
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 PORTERS FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITION RIVALRY
5.9 REGULATORY LANDSCAPE
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.1 TRADE ANALYSIS (HS CODE)
5.11 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE TREND OF DIFFERENT TYPE OF MEDIA/1000L IN DEVELOPED AND DEVELOPING REGION (2022)
5.12 PATENT ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2023
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
6 CELL CULTURE MEDIA MARKET, BY TYPE
6.1 INTRODUCTION
6.1.1 SERUM FREE MEDIA
6.1.1.1 CHO MEDIA
6.1.1.2 HEK 293 MEDIA
6.1.1.3 BHK MEDIA
6.1.1.4 VERO CELL MEDIA
6.1.1.5 SERUM-FREE STEM CELL MEDIA
6.1.1.6 INSECT CELL MEDIA
6.1.1.7 IMMUNE CELL MEDIA
6.1.1.8 OTHER SERUM-FREE MEDIA
6.1.2 CLASSICAL MEDIA & SALTS
6.1.3 STEM CELL CULTURE MEDIA
6.1.4 CHEMICALLY DEFINED (CD) MEDIA
6.1.5 SPECIALTY MEDIA
6.1.6 OTHER CELL CULTURE MEDIA
7 CELL CULTURE MEDIA MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 BIOPHARMACEUTICAL PRODUCTION
7.2.1 MONOCLONAL ANTIBODY PRODUCTION
7.2.2 VACCINE PRODUCTION
7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
7.3 DIAGNOSTICS
7.4 DRUG SCREENING & DEVELOPMENT
7.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE
7.5.1 CELL & GENE THERAPY
7.5.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
7.6 OTHER APPLICATIONS
8 CELL CULTURE MEDIA MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
8.4 RESEARCH & ACADEMIC INSTITUTES
8.5 OTHER END USERS
9 CELL CULTURE MEDIA MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 RECESSION IMPACT
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.3.7 RECESSION IMPACT
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 REST OF ASIA PACIFIC
9.4.6 RECESSION IMPACT
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.2 MEXICO
9.5.3 REST OF LATIN AMERICA
9.5.4 RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
10.3 MARKET SHARE ANALYSIS (2022)
10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2020-2022)
10.5 COMPANY EVALUATION QUADRANT, 2022
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 COMPETITIVE BENCHMARKING OF TOP PLAYERS
10.7 COMPANY EVALUATION QUADRANT FOR START-UP/SMES
10.7.1 PROGRESSIVE COMPANIES
10.7.2 STARTING BLOCKS
10.7.3 RESPONSIVE COMPANIES
10.7.4 DYNAMIC COMPANIES
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
10.9 COMPETITIVE SCENARIO
10.9.1 OVERVIEW
10.9.2 PRODUCT LAUNCHES
10.9.3 DEALS
10.9.4 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 THERMO FISHER SCIENTIFIC, INC.
11.1.2 MERCK KGAA
11.1.3 DANAHER CORPORATION
11.1.4 SARTORIUS AG
11.1.5 CORNING INCORPORATED
11.1.6 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION)
11.1.7 LONZA GROUP
11.1.8 BECTON, DICKINSON AND COMPANY (BD)
11.1.9 MILTENYI BIOTEC
11.1.10 HIMEDIA LABORATORIES PVT. LTD.
11.1.11 STEMCELL TECHNOLOGIES INC.
11.1.12 BIOLOGOS LLC.
11.2 OTHER PLAYERS
11.2.1 CELL APPLICATIONS, INC.
11.2.2 CAISSON LABS INC.
11.2.3 PROMOCELL GMBH
11.2.4 CELL BIOLOGICS, INC.
11.2.5 INVIVOGEN
11.2.6 PAN-BIOTECH GMBH
11.2.7 CELLULAR TECHNOLOGY LIMITED LLC.
11.2.8 ZENBIO, INC
11.2.9 CYAGEN BIOSCIENCES
11.2.10 BIOWEST SAS
11.2.11 AKRON BIOTECH
11.2.12 ATHENA ENVIRONMENTAL SCIENCES, INC.
11.2.13 KCELL BIOSCIENCES
11.2.14 WELGENE INC.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS